Kemper
- Market cap
- 1.55B
- P/E (TTM)i
- -3.16
- P/Bi
- 0.71
- EPSi
- 2.29
- Div yieldi
- 4.88%
- 52W posi
- 15%
Anonymous reader poll. Unscientific, not investment advice.
Valuation each multiple against its own 5-year range
Vs. peers Insurance - Property & Casualty
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Kemper (KMPR) | 1.55B | -3.16 | 0.71 | 4.88% |
| Chubb Ltd (CB) | 129.13B | 11.86 | 1.71 | 1.17% |
| Progressive (PGR) | 124.28B | 10.74 | 3.62 | 6.49% |
| The Travelers Companies (TRV) | 75.21B | 9.69 | 2.27 | 1.26% |
| Allstate (ALL) | 56.63B | 4.48 | 1.79 | 1.86% |
| WR Berkley (WRB) | 25.89B | 14.35 | 2.63 | 0.53% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 47.5% below Morningstar's fair value estimate.
Fair value
Kemper Corp may seem undervalued at first glance, due to its considerable price decline over the past year. However, to account for the risk associated with a potential value trap, we have limited its rating to 3 stars. The stock currently trades at a 33% discount to our quantitative fair value estimate of $38.71 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The firm's balance sheet bolsters our fair value estimate. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. For example, the firm's EBITDA/interest coverage ratio of -11.4 sits in the bottom 10% globally. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. We believe this is a sign that shares could be cheap.
Conversely, the company's lack of growth is potentially concerning. Stagnant revenue and earnings growth indicates a company's challenges in increasing market share and profitability. The firm's revenue 5-year growth of -4.8%, for example, falls in the bottom 20% compared with peers globally. Weak trailing five-year revenue growth is disappointing and could indicate trouble generating future value for shareholders, which, despite our favorable price/fair value ratio, is a negative attribute.
Economic moat
With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-10-08 04:03:22 · For reference only, not investment advice and not tailored to your situation.